Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series.
Docosahexaenoic Acid and Cognition throughout the Lifespan.
Low degree of cortical pathology is associated with benign course of multiple sclerosis.
The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model.
Impaired functional integration in multiple sclerosis: a graph theory study.
Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.
Jean-Martin Charcot, father of modern neurology: an homage 120 years after his death.
Evasion of Antiviral Innate Immunity by Theiler's Virus L* Protein through Direct Inhibition of RNase L.
Relapsing Remitting Multiple Sclerosis Patients Initiated on Oral Dmf Report A Better Quality of Life Compared to Patients on Platform Therapies As Measured By Eq-5d.
The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis.
Investigation-Directed Approach to Inflammatory Optic Neuropathies.
Tract-based spatial statistics of the olfactory brain in patients with multiple sclerosis.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: Commentary.
Verbal Fluencies and Fampridine Treatment in Multiple Sclerosis.
The current role of mitoxantrone in the treatment of multiple sclerosis.
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring.
Tumefactive demyelinating disease with isolated spinal cord involvement.
Fingolimod effects on left ventricular function in multiple sclerosis.
[STUDY ON RELATIONSHIP BETWEEN DIFFUSION TENSOR IMAGING AND VISUAL EVOKED POTENTIAL IN VISUAL PATHWAY OF NEUROMYELITIS OPTICA].
Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection.
[MELATONIN TREATMENT OF AUTOIMMUNE AND ALLERGIC PATHOLOGY].
Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica.
Neuroimaging assessment of spasticity developed after acquired brain injuries and multiple sclerosis.
Subretinal angiostrongyliasis-induced optic neuritis.
Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types.
Pages
« first
‹ previous
…
510
511
512
513
514
515
516
517
518
…
next ›
last »